Listed company directorships are one of the most consistently missed elements in private banking SOW reviews. Not because they're obscure — they're publicly disclosed on SGX, on annual reports, on company websites. Because nobody checked. The RM didn't ask. The reviewer didn't search. The file went through without it.
When it surfaces in QA — and it does surface, because external reviewers do run public registry checks — it creates a problem that's harder to close than the original omission. It's not just a documentation gap anymore. It's a process failure. And those require a different response than a simple remediation note.
Why Listed Directorships Get Missed
The private banking SOW methodology is built around private wealth structures — business ownership, property, inheritance, savings. Listed company directorships sit in a different mental category for most RMs. The client is a director, not necessarily a major shareholder. The role may be non-executive. The fee may be modest. The RM concludes it's not material to the wealth story and doesn't raise it.
That reasoning is sometimes correct. What makes it a process failure rather than a judgment call is when the reasoning was never applied at all — when the directorship simply wasn't on anyone's radar during the review.
The distinction between a judgment call and a process failure is documentation. A judgment call has a rationale in the file. A process failure has nothing — because nothing was considered.
SGX-listed company directors have public disclosure obligations. Their names are on public record. The fact that a directorship acquired six months before a SOW review wasn't captured doesn't just mean the file is incomplete. It means the review process didn't include a public registry check — or if it did, the results weren't cross-referenced against the client profile.
The Immateriality Argument — When It Works and When It Doesn't
The instinctive response when a listed directorship omission surfaces is to reach for immateriality. The shareholding is small. The director fee is modest. The quantum represents less than 1% of declared net worth. Case closed.
That argument is often correct on the numbers. Where it breaks down is in the framing. Immateriality closes a documentation gap. It doesn't remediate a process failure. If Compliance or an external auditor raises the omission, a pure immateriality response leaves one question unanswered: how did this get missed in the first place, and what ensures it won't happen again?
Part 1 — Acknowledge the omission explicitly. The directorship and shareholding existed at the time of the SOW review and were not captured. State this directly. Don't soften it into "was not reflected in the current version" — that's evasion, and experienced reviewers read it as such.
Part 2 — Assert immateriality on quantum, with the right price. This is the technical piece that most responses get wrong. The share value used in the immateriality calculation must be the price at the time of the SOW completion — not today's price. A stock that has declined 50% since the review date produces a materially different immateriality calculation at today's price versus the review date price. Using today's lower price to strengthen an immateriality argument is a mistake that Compliance will catch.
Part 3 — Commit to a KYC update. Immateriality on quantum doesn't mean the directorship disappears from the file. The KYC record needs to be updated to reflect the directorship and shareholding. This is what converts an acknowledged gap into a properly remediated finding. Without the update commitment, the finding stays technically open regardless of the immateriality assessment.
The Share Price Problem
This is the detail that trips up otherwise well-constructed immateriality responses. Consider a client whose SOW was completed in January, who holds shares in a listed company. By the time the omission is raised in a QA review in June, the share price may have moved significantly — in either direction.
If the stock has declined, using the current price produces a lower shareholding value and a more comfortable immateriality percentage. But it's the wrong number. The immateriality assessment has to be anchored to the point at which the review was conducted — the price at SOW completion date — because that's when the decision was made and the omission occurred.
Conversely, if the stock has risen since the review date, the immateriality argument may be stronger at the review date price than at today's price. Either way, the principle is the same: use the price that was applicable when the review happened, not the price that's most convenient when the response is being written.
Using today's share price in an immateriality calculation for a SOW omission that was identified at a different point in time. The calculation must reference the price at SOW completion date. Compliance reviewers and external auditors will check. A response that uses a selectively lower price to strengthen an immateriality case creates a credibility problem that is harder to manage than the original omission.
What the File Should Show After Remediation
A properly remediated listed company omission has four elements in the file:
- Acknowledgment of the omission — explicit, dated, stating when the directorship was acquired and why it was not captured at review
- Immateriality assessment at review-date price — shareholding value calculated at the share price on SOW completion date, expressed as a percentage of declared net worth at that time
- Director fee assessment — annual fee verified from the company's annual report, assessed against declared income profile
- KYC update commitment — confirmation that the directorship and shareholding will be reflected in the KYC record at the next scheduled review, or earlier if a material change occurs
The Broader Lesson for Listed Company Clients
Private banking clients who hold listed company directorships present a specific SOW challenge that differs from private company ownership. The information is publicly available — which means the standard for having captured it is higher, not lower. An RM who misses a private company shareholding can credibly argue the information wasn't readily accessible. An RM who misses an SGX-listed directorship that appears on the company's annual report cannot make the same argument.
The practical implication is that the SOW review process for any client with known business activities should include a public registry and stock exchange search as a standard step — not an optional one. SGX's listed company director disclosure is searchable. It takes minutes. The finding it prevents is worth considerably more than the time it takes.
For clients where the directorship is known but assessed as non-material to the wealth story, that assessment needs to be in the file. Not as an absence of information, but as a documented judgment: the directorship exists, the quantum was assessed, and the conclusion was that it does not materially affect the SOW narrative. That's a defensible position. Silence on the matter is not.
Listed company omissions are avoidable. The information is public, the search takes minutes, and the remediation — when it's needed — is straightforward if the response is constructed correctly. What makes them expensive is not the omission itself. It's the follow-up that gets handled poorly: the wrong share price, the missing KYC update commitment, the immateriality argument that closes the quantum question without addressing the process failure behind it.
Write the acknowledgment. Use the right price. Commit to the update. In that order.